Daily Nighttime Melatonin Reduces Blood Pressure in Male Patients with Essential Hypertension

Hypertension

Volumn 43, Issue 2 I, 2004, Pages 192-197

  Scheer, Frank A J L ^a,d   Van Montfrans, Gert A ^b   Van Someren, Eus J W ^a,c   Mairuhu, Gideon ^b   Buijs, Ruud M ^a  

^a NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Blood pressure monitoring; Circadian rhythm; Hormones; Human; Hypertension

Indexed keywords

MELATONIN; PLACEBO;

ACTIMETRY; ADULT; AGED; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CARDIOVASCULAR SYSTEM; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; ESSENTIAL HYPERTENSION; HEART RATE; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SINUS NODE; SLEEP PATTERN; TREATMENT OUTCOME;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CIRCADIAN RHYTHM; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; HUMANS; HYPERTENSION; MALE; MELATONIN; MIDDLE AGED; SLEEP; WAKEFULNESS;

EID: 0842332600     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000113293.15186.3b     Document Type: Article

References (43)

1. Buijs RM, Kalsbeek A. Hypothalamic integration of central and peripheral clocks. Nat Rev Neurosci. 2001;2:521-526.
2. Buijs RM, Wortel J, Van Heerikhuize JJ, Feenstra MGP, Ter Horst GJ, Romijn HJ, Kalsbeek A. Anatomical and functional demonstration of a multisynaptic suprachiasmatic nucleus adrenal (cortex) pathway. Eur J Neurosci. 1999;11:1535-1544.
3. Scheer FAJL, Buijs RM. Light affects morning salivary cortisol in humans. J Clin Endocrinol Metab. 1999;84:3395-3398.
4. Scheer FAJL, van Doomen LJP, Buijs RM. Light and diurnal cycle affect human heart rate: possible role for the circadian pacemaker. J Biol Rhythms. 1999;14:202-212.
5. Scheer FAJL, Ter Horst GJ, Van der Vliet J, Buijs RM. Physiological and anatomic evidence for regulation of the heart by suprachiasmatic nucleus in rats. Am J Physiol. 2001;280:H1391-H1399.
6. Fleur SEL, Kalsbeek A, Wortel J, Buijs RM. Polysynaptic neural pathways between the hypothalamus, including the suprachiasmatic nucleus, and the liver. Brain Res. 2000;871:50-56.
7. Klein DC, Weller JL. Rapid light-induced decrease in pineal serotonin N-acethyltransferase activity. Science. 1972;177:532-533.
8. Guzzetti S, Dassi S, Pecis M, Casati R, Masu AM, Longoni P, Tinelli M, Cerutti S, Pagani M, Malliani A. Altered pattern of circadian neuronal control of heart period in mild hypertension. J Hypertens. 1991;9:831-838.
9. Nakano Y, Oshima T, Ozono R, Higashi Y, Sasaki S, Matsumoto T, Matsuura H, Chayama K, Kambe M. Non-dipper phenomenon in essential hypertension is related to blunted nocturnal rise and fall of sympatho-vagal nervous activity and progress in retinopathy. Auton Neurosci. 2001;88:181-186.
10. Shaw JA, Chin-Dusting JP, Kingwell BA, Dart AM. Diurnal Variation in Endothelium-Dependent Vasodilatation Is Not Apparent in Coronary Artery Disease. Circulation. 2001;103:806-812.
11. Brugger P, Marktl W, Herold M. Impaired secretion of melatonin in coronary heart disease. Lancet. 1995;345:1408.
12. Goncharuk VD, Heerikhuize JV, Dai JP, Swaab DF, Buijs RM. Neuropeptide changes in the suprachiasmaic nucleus in primary hypertension indicate functional impairment of the biological clock. J Comp Neurol. 2001;431:320-330.
13. Goncharuk VD, Van Heerikhuize J, Swaab DF, Buijs RM. Paraventricular nucleus of the human hypothalamus in primary hypertension: activation of corticotropin-releasing hormone neurons. J Comp Neurol. 2002;443:321-331.
14. Muller JE, Tofler GH, Stone PH. Circadian variation and triggers of onset of acute cardiovascular disease. Circulation. 1989;79:733-743.
15. Stergiou GS, Vemmos KN, Pliarchopoulou KM, Synetos AG, Roussias LG, Mountokalakis TD. Parallel morning and evening surge in stroke onset, blood pressure, and physical activity. Stroke. 2002;33:1480-1486.
16. Reppert SM, Weaver DR, Rivkees SA, Stopa EG. Putative melatonin receptors in a human biological clock. Science. 1988;242:78-83.
17. Weaver DR, Reppert SM. The Mella melatonin receptor gene is expressed in human suprachiasmatic nuclei. Neuroreport 1996;8:109-112.
18. Zaidan R, Geoffriau M, Brun J, Taillard J, Bureau C, Chazot G, Claustrat B. Melatonin is able to influence its secretion in humans description of a phase-response curve. Neuroendocrinology. 1994;60:105-112.
19. Bothorel B, Barassin S, Saboureau M, Perreau S, Vivien-Roels B, Malan A, Pevet P. Exogenous melatonin increases the amplitude of the pineal melatonin secretion by a direct action on the circadian clock in the rat. Eur J Neurosci. 2002;16:1-10.
20. Arendt J, Bojkowski C, Folkard S, Franey C, Marks V, Minors D, Waterhouse J, Wever RA, Wildgruber C, Wright J. Some effects of melatonin and the control of its secretion in humans. Ciba Found Symp. 1985;117:266-283.
21. Mishima K, Okawa M, Hozumi S, Hishikawa Y. Supplementary administration of artificial bright light and melatonin as potent treatment for disorganized circadian rest-activity and dysfunctional autonomic and neuroendocrine systems in institutionalized demented elderly persons. Chronobiol Int. 2000;17:419-432.
22. Sharkey KM, Eastman CI. Melatonin phase shifts human circadian rhythms in a placebo-controlled-simulated night-work study. Am J Physiol. 2002;282:R454-463.
23. Sack RL, Brandes RW, Kendall AR, Lewy AJ. Entrainment of free-running circadian rhythms by melatonin in blind people. N Engl J Med. 2000;343:1070-1077.
24. Sly DJ, Colvill L, McKinley MJ, Oldfield BJ. Identification of neural projections from the forebrain to the kidney, using the virus pseudorabies. J Autonom Nerv Syst. 1999;77:73-82.
25. Guidelines Subcommittee. 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. J Hypertens. 1999;17:151-183.
26. O'Brien E, Beevers G, Lip GY. ABC of hypertension. Blood pressure measurement. Part III-automated sphygmomanometry: ambulatory blood pressure measurement. Br Med J. 2001;322:1110-1114.
27. Altman DG. Crossover trials, vol 1. London: Chapman and Hall; 1991.
28. Staessen JA, Wang JG, Thijs L. Cardiovascular protection and blood pressure reduction: a meta-analysis. Lancet. 2001;358:1305-1315.
29. Staessen JA, Thijs L, Fagard R, O'Brien ET, Clement D, de Leeuw PW, Mancia G, Nachev C, Palatini P, Parati G, Tuomilehto J, Webster J. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators. JAMA. 1999;282:539-546.
30. Birau N, Peterssen U, Meyer C, Gottschalk J. Hypotensive effect of melatonin in essential hypertension. IRCS Med Sci, 1981;9:906.
31. Lusardi P, Piazza E, Fogari R. Cardiovascular effects of melatonin in hypertensive patients well controlled by nifedipine: a 24-hour study. Br J Clin Pharmacol. 2000;49:423-427.
32. Savaskan E, Olivieri G, Brydon L, Jockers R, Krauchi K, Wirz-Justice A, Muller-Spahn F. Cerebrovascular melatonin MT1-receptor alterations in patients with Alzheimer's disease. Neurosci Lett. 2001;308:9-12.
33. Reppert SM, Godson C, Mahle CD, Weaver DR, Slaugenhaupt SA, Gusella JF. Molecular characterization of a second melatonin receptor expressed in human retina and brain: the Me11b melatonin receptor. Proc Natl Acad Sci U S A. 1995;92:8734-8738.
34. Ekmekcioglu C, Haslmayer P, Philipp C, Mehrabi MR, Glogar HD, Grimm M, Thalhammer T, Marktl W. 24h variation in the expression of the mt, melatonin receptor subtype in coronary arteries derived from patients with coronary heart disease. Chronobiol Int. 2001;18:973-985.
35. Nishiyama K, Yasue H, Moriyama Y, Tsunoda R, Ogawa H, Yoshimura M, Kugiyama K. Acute effects of melatonin administration on cardiovascular autonomic regulation in healthy men. Am Heart J. 2001;141;E9.
36. McNamara P, Seo S, Rudic RD, Sehgal A, Chakravarti D, FitzGerald GA. Regulation of clock and mop4 by nuclear hormone receptors in the vasculature. a humoral mechanism to reset a peripheral clock. Cell. 2001;105:877-889.
37. Van Cauter E, Leproult R, Plat L. Age-related changes in slow wave sleep and REM sleep and relationship with growth hormone and cortisol levels in healthy men. JAMA. 2000;284:861-868.
38. van den Top M, Buijs RM, Ruijter JM, Delagrange P, Spanswick D, Hermes ML. Melatonin generates an outward potassium current in rat suprachiasmatic nucleus neurones in vitro independent of their circadian rhythm. Neuroscience. 2001;107:99-108.
39. Cagnacci A, Elliott JA, Yen SS. Melatonin: a major regulator of the circadian rhythm of core temperature in humans. J Clin Endocrinol Metab. 1992;75:447-452.
40. Kushida CA, Chang A, Gadkary C, Guilleminault C, Carrillo O, Dement WC. Comparison of actigraphic, polysomnographic, and subjective assessment of sleep parameters in sleep-disordered patients. Sleep Med. 2001;2:389-396.
41. Aldhous M, Franey C, Wright J, Arendt J. Plasma concentrations of melatonin in man following oral absorption of different preparations. Br J Clin Pharmacol. 1985;19:517-521.
42. Batschelet E. Circular Statistics in Biology. London: Academic Press; 1981.
43. de Leeuw J. Introduction to Akaike (1973) information theory and an extension of the maximum likelihood principle. In: Kotz S, Johnson NL, eds, Breakthroughs in statistics, vol 1. London: Springer-Verlag; 1992:599-609.